Your account is not claimed yet. You can sign up with ORCID to claim your account.

Christopher Montemagno

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Cancers

International journal of molecular sciences

Autophagy

Cancer research communications

Centre Scientifique de Monaco

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Scientifique de Monaco May 1o 2019

Monaco

Post-doc :: Biomedical department

Publications

William Echavidre, Jérôme Durivault, Célia Gotorbe, Thays Blanchard, Marina Pagnuzzi, Valérie Vial, Florian Raes, Alexis Broisat, Rémy Villeneuve, Régis Amblard, Nicolas Garnier, Cécile Ortholan, Marc Faraggi, Benjamin Serrano, Vincent Picco, Christopher Montemagno
Integrin-αvβ3 is a therapeutically targetable fundamental factor in medulloblastoma tumorigenicity and radioresistance. Cancer research communications (2023)
Sandy Giuliano, Christopher Montemagno, Marie-Angela Domdom, Manon Teisseire, Patrick Brest, Daniel J Klionsky, Paul Hofman, Gilles Pagès, Baharia Mograbi
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD? Autophagy (2023)
William Echavidre, Daniel Fagret, Marc Faraggi, Vincent Picco, Christopher Montemagno
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future. Cancers 15 (19) (2023)
William Echavidre, Vincent Picco, Marc Faraggi, Christopher Montemagno
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future? Pharmaceutics 14 (5) (2022)
Marina Pagnuzzi-Boncompagni, Vincent Picco, Valérie Vial, Victor Planas-Bielsa, Ashaina Vandenberghe, Thomas Daubon, Marie-Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin, Sonia Martial, Jérôme Doyen, Julie Gavard, Gilles Pagès
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma. Cancers 14 (1) (2021)
Aurore Dumond, Christopher Montemagno, Valérie Vial, Renaud Grépin, Gilles Pagès
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas. Cells 10 (5) (2021)
Christopher Montemagno, Florian Raes, Mitra Ahmadi, Sandrine Bacot, Marlène Debiossat, Leenhardt Julien, Jean Boutonnat, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Catherine Ghezzi, Pascale Perret, Alexis Broisat
In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor. Cancers 13 (5) (2021)
Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, Jérôme Durivault, Marc Faraggi, Gilles Pagès
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine? International journal of molecular sciences 22 (12) (2021)
Christopher Montemagno, Gilles Pagès
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine. Cancers 12 (4) (2020)
Christopher Montemagno, Shamir Cassim, Jacques Pouysségur, Alexis Broisat, Gilles Pagès
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. International journal of molecular sciences 21 (11) (2020)

Christopher Montemagno.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher Montemagno